FAMOTIDINE AS COVID-19 APPROACH FOR DRUG DELIVERY AND REDUCES MORTALITY
Dr. Jagpal Singh*, Jonny Kumar, Abdul Mannan and Bhawna Sharma
ABSTRACT
Despite multiple trials that are currently underway to investigate the safety and efficacy of a large number of possible therapeutic agents, no drug available to reduced COVID-19 mortality. The famotidine is commonly used for gastric acid suppression but has recently affected and achieved via its antagonism of histamine -2 receptor, inferring that the SARS-CoV-2 infection that results in COVID-19 occurs, can be partially medicated by pathological histamine release. As histamine-2 receptor antagonist, famotidine is a therapeutic option in COVID-19 positive patient therapy.
[Full Text Article] [Certificate Download]
